Subcutaneous Drug Delivery Devices Market Analysis to 2027

The subcutaneous drug delivery devices market was valued at US$ 9,243.80 million in 2018 and it is projected to reach US$ 17,290.47 million in 2027; it is expected to grow at a CAGR of 7.4% from 2019 to 2027.

Subcutaneous drug delivery refers to a process that involves administration of medication or medicine under the skin. In the subcutaneous drug delivery process, a small needle is used to inject the drug in the tissue present in between muscle and skin. The drug is usually injected in low volumes, which varies between 1 mL to 2mL. For instance, insulin is widely administered through subcutaneous injection. The abdomen, arm, and thigh are the most common injection sites for subcutaneous injection. The growth of the global subcutaneous drug delivery devices market is attributed to the increased number of chronic disease, increasing R&D expenditures in pharmaceutical and medical device companies and technological advancements and increasing product launches. However, risk of infections and other diseases associated with the use of injections and syringes is the major factor hindering the market growth.

The global subcutaneous drug delivery devices market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years. 

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

Subcutaneous Drug Delivery Devices Market: Strategic Insights

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

Market Insights

Increasing R&D Expenditures in Pharmaceutical and Medical Device Companies to Drive Global Subcutaneous Drug Delivery Devices Market Growth

Research and development (R&D) is an essential and crucial part of the company’s business. Pharmaceutical and medical devices companies focus on the research and development (R&D) to come up with new molecules for various therapeutic applications with the greatest medical and commercial potential. The companies invest majorly on the R&Ds with the aim of delivering high quality and innovative products to the market.

R&D spending by the biopharmaceutical companies has also increased over the years. According to a report of Pharmaceutical Research and Manufacturers of America (PhRMA), the R&D expenditure of the biopharmaceutical companies has increased from US$49.6 billion 2012 to US$ 58.8 billion in 2015. Also, Evonik Corporation has invested more than $50 million over the last 4 years to advance its competencies in medical devices, and production of RESOMER polymers for drug delivery and bio reabsorbable medical devices.

Thus the growing R&D expenditure drives the subcutaneous drug delivery systems market during the forecast period.

Technology -Based Insights

In terms of technology, the global subcutaneous drug delivery devices market is segmented into syringes, pens, patches and others. In 2018, the syringes segment held largest share of the market. However, the patches segment is estimated to grow at the fastest rate during the forecast period.

Syringe Type-Based Insights

In terms of syringe type, the global subcutaneous drug delivery devices market is segmented into prefilled injectable and fillable injectable. In 2018, the fillable injectable segment held largest share of the market. However, the prefilled injectable segment is expected to register the highest CAGR during the forecast period.

Subcutaneous Drug Delivery Devices Market Regional Insights

The regional trends and factors influencing the Subcutaneous Drug Delivery Devices Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Subcutaneous Drug Delivery Devices Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Subcutaneous Drug Delivery Devices Market Report Scope

Market Players Density: Understanding Its Impact on Business Dynamics

The Subcutaneous Drug Delivery Devices Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the Subcutaneous Drug Delivery Devices Market are:

1. Insulet Corporation
2. BD
3. Enable Injections
4. Consort Medical Plc
5. West Pharmaceutical Services, Inc.

Disclaimer: The companies listed above are not ranked in any particular order.

Distribution Channel-Based Insights

In terms of distribution channel, the global subcutaneous drug delivery devices market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest share of the market in 2018, and the same segment is estimated to grow at the fastest rate during the forecast period.

The global subcutaneous drug delivery devices market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.

Global Subcutaneous Drug Delivery Devices Market – by Technology

• Syringes
• Pens
• Patches
• Others  

Global Subcutaneous Drug Delivery Devices Market – by Syringe Type

• Prefilled Injectable
• Fillable Injectable

Global Subcutaneous Drug Delivery Devices Market – by Distribution Channel

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

Global Subcutaneous Drug Delivery Devices Market – by Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • Italy
  • UK
  • Spain
  • Rest of Europe
• Asia Pacific (APAC)
  • China
  • India
  • South Korea
  • Japan
  • Australia
  • Rest of APAC
• Middle East & Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of MEA
• South America and Central America (SCAM)
  • Brazil
  • Argentina
  • Rest of SCAM

Company Profiles

• Insulet Corporation
• BD
• Enable Injections
• Consort Medical Plc
• West Pharmaceutical Services, Inc.
• Elcam Medical
• Amgen
• Ypsomed AG
• SCPharmaceuticals, Inc.
• Wilhelm Haselmeier GmbH & Co. KG